Abstract
We evaluated the efficacy of an oral appliance (OA) for the treatment of snoring and obstructive sleep apnea (OSA) syndrome in 19 adult patients. Ten of 19 patients were assessed by a nocturnal apnomonitor before and after the treatment. The snoring improved in 17 of 19 patients (89.5%).
The oxygen desaturation index (ODI) was reduced to below 10 in 7 of 10 patients (70%). OA therapy is more effective in patients with mild or moderate OSA than in patients with severe OSA. These results indicate that OA therapy is useful not only for snoring but also for OSA.